EX-99.1 2 a03312025-ex991earningsrel.htm EX-99.1 Document

Exhibit 99.1
Insperity Announces First Quarter Results
HOUSTON – April 29, 2025 – Insperity, Inc. (NYSE: NSP), a leading provider of human resources and business performance solutions for America’s best businesses, today reported results for the first quarter ended March 31, 2025. Insperity will be hosting a conference call today at 8:30 a.m. ET to discuss these results and our updated 2025 outlook and will be posting an accompanying presentation to its investor website at http://ir.insperity.com.
Q1 average number of WSEEs up 1% and revenues up 3% year-over-year
Q1 net income of $51 million; adjusted EBITDA of $102 million
Q1 diluted EPS of $1.35; adjusted EPS of $1.57
Return to shareholders of $42 million during the first three months of 2025 through the repurchase of 224,000 shares at a cost of $19 million and $23 million in cash dividends
First Quarter Results
The average number of worksite employees (“WSEE”) paid per month increased 1% from Q1 2024 to 306,023 WSEEs. Revenues in Q1 2025 increased 3% to $1.9 billion on a 3% increase in revenue per WSEE on higher pricing and the increase in paid WSEEs.
“Our first quarter financial results, reflecting macro-economic turbulence and healthcare cost volatility, are in stark contrast with the solid execution of our game plan for building the foundation for future growth acceleration,” said Paul J. Sarvadi, Insperity chairman and chief executive officer. “We also made excellent progress on our Workday strategic partnership milestones, including an agreed upon go-to-market plan that we expect will add a new driver to our growth in 2026 and beyond.”
Gross profit decreased 10% to $310 million in Q1 2025 from $345 million in Q1 2024 due primarily to higher-than-expected benefits costs. Other areas of gross profit, including pricing, workers’ compensation program and payroll taxes were in line with our expectations. Higher Q1 2025 healthcare costs were driven by an acceleration in inpatient, outpatient, and pharmacy costs and in the frequency of large claim activity. Healthcare costs include approximately $12 million of higher-than-expected runoff from claims related to prior periods.
Operating expenses increased 2% to $242 million in Q1 2025 from $237 million in Q1 2024. Operating expenses included $13 million and $5 million for our Workday strategic partnership in Q1 2025 and Q1 2024, respectively.
Reported net income and diluted EPS were $51 million and $1.35, respectively. Adjusted EBITDA and adjusted EPS were $102 million and $1.57, respectively.
“We have made good progress with our operating plan in 2025, with a focus on operating expense management and accelerating growth,” said James D. Allison, executive vice president of finance, chief financial officer and treasurer. “Given the elevated level of healthcare costs in the quarter, we have initiated a pricing plan to address the projected higher healthcare cost trend. We also have other options under evaluation that could contain or reduce costs and drive improved profitability in 2026.”
Cash outlays in the first three months of 2025 included the repurchase of approximately 224,000 shares of our common stock at a cost of $19 million, dividends totaling $23 million, and capital expenditures of $6 million. Adjusted cash at March 31, 2025 totaled $124 million and $280 million remains available under our $650 million credit facility.



2025 Guidance
The company also announced its updated guidance for 2025, including the second quarter of 2025. Please refer to the accompanying financial tables at the end of this press release for the reconciliation of non-GAAP financial measures to the comparable GAAP financial measures.
Q2 2025Full Year 2025
Average WSEEs paid308,000311,000308,800316,400
Year-over-year increase
0.3%1.3%0.5%3.0%
Adjusted EPS$0.29$0.67$2.23$3.28
Year-over-year decrease
(66)%(22)%(38)%(8)%
Adjusted EBITDA (in millions)$33$53$190$245
Year-over-year decrease
(50)%(20)%(30)%(9)%
Definition of Key Metrics
Average WSEEs paid — Determined by calculating the company’s cumulative WSEEs paid during the period divided by the number of months in the period.
Adjusted EPS — Represents diluted net income per share computed in accordance with GAAP, excluding the impact of non-cash stock-based compensation.
Adjusted EBITDA — Represents net income computed in accordance with GAAP, plus interest expense, income taxes, depreciation and amortization expense, amortization of SaaS implementation costs and non-cash stock-based compensation.
Conference Call and Webcast
Insperity will be hosting a conference call today at 8:30 a.m. ET to discuss these results and the guidance discussed in this press release, and answer questions from investment analysts. To listen in, call 888-506-0062 and use conference i.d. number 634912. The call will also be webcast at http://ir.insperity.com. The conference call script will be available at the same website later today. A replay of the conference call will be available at 877-481-4010, conference i.d. number 52321. The webcast will be archived for one year.
About Insperity
Since 1986, Insperity’s mission has been to help businesses succeed so communities prosper. Offering the most comprehensive suite of scalable HR solutions available in the marketplace, Insperity is defined by an unrivaled breadth and depth of services and level of care. Through an optimal blend of premium HR service and technology, Insperity delivers the administrative relief, reduced liabilities and better benefit solutions that businesses need for sustained growth. With 2024 revenues of $6.6 billion and more than 100 sales offices throughout the U.S., Insperity is currently making a difference in thousands of businesses and communities nationwide. For more information, visit http://www.insperity.com.



Forward-Looking Statements
The statements contained herein that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You can identify such forward-looking statements by the words “anticipates,” “expects,” “intends,” “plans,” “projects,” “believes,” “estimates,” “forecasts,” “likely,” “possibly,” “probably,” “could,” “goal,” “opportunity,” “objective,” “target,” “assume,” “outlook,” “guidance,” “predicts,” “appears,” “indicator” and similar expressions. Forward-looking statements involve a number of risks and uncertainties. In the normal course of business, in an effort to help keep our stockholders and the public informed about our operations, from time to time, we may issue such forward-looking statements, either orally or in writing. Generally, these statements relate to business plans or strategies, including our strategic partnership with Workday, Inc.; projected or anticipated benefits or other consequences of such plans or strategies; or projections involving anticipated revenues, earnings, average number of worksite employees, benefits and workers’ compensation costs, or other operating results. We base these forward-looking statements on our current expectations, estimates and projections. We caution you that these statements are not guarantees of future performance and involve risks, uncertainties and assumptions that we cannot predict. In addition, we have based many of these forward-looking statements on assumptions about future events that may prove to be inaccurate. Therefore, the actual results of the future events described in such forward-looking statements could differ materially from those stated in such forward-looking statements. Among the factors that could cause actual results to differ materially are:
adverse economic conditions;
failure to comply with or meet client expectations regarding certain COVID-19 relief programs;
bank failures or other events affecting financial institutions;
labor shortages, increasing competition for highly skilled workers, and evolving employee expectations regarding the workplace;
impact of inflation;
vulnerability to regional economic factors because of our geographic market concentration;
failure to comply with covenants under our credit facility;
impact of a future outbreak of highly infectious or contagious disease;
our liability for WSEE payroll, payroll taxes and benefits costs, or other liabilities associated with actions of our client companies or WSEEs, including if our clients fail to pay us;
increases in health insurance costs and workers’ compensation rates and underlying claims trends, health care reform, financial solvency of workers’ compensation carriers, other insurers or financial institutions, state unemployment tax rates, liabilities for employee and client actions or payroll-related claims;
an adverse determination regarding our status as the employer of our WSEEs for tax and benefit purposes and an inability to offer alternative benefit plans following such a determination;
cancellation of client contracts on short notice, or the inability to renew client contracts or attract new clients;
the ability to secure competitive replacement contracts for health insurance and workers’ compensation insurance at expiration of current contracts;
regulatory and tax developments and possible adverse application of various federal, state and local regulations;
failure to manage growth of our operations and the effectiveness of our sales and marketing efforts;
the impact of the competitive environment and other developments in the human resources services industry, including the PEO industry, on our growth and/or profitability;
an adverse final judgment or settlement of claims against Insperity;
disruptions of our information technology systems or failure to enhance our service and technology offerings to address new regulations or client expectations;
our liability or damage to our reputation relating to disclosure of sensitive or private information as a result of data theft, cyberattacks or security vulnerabilities;
failure of third-party providers, such as financial institutions, data centers or cloud service providers;
our ability to fully realize the anticipated benefits of our strategic partnership and plans to develop a joint solution with Workday, Inc.; and
our ability to integrate or realize expected returns on future product offerings, including through acquisitions, strategic partnerships, and investments.
These factors are discussed in further detail in Insperity’s filings with the U.S. Securities and Exchange Commission. Any of these factors, or a combination of such factors, could materially affect the results of our operations and whether forward-looking statements we make ultimately prove to be accurate.
Any forward-looking statements are made only as of the date hereof and, unless otherwise required by applicable securities laws, we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


SUMMARY FINANCIAL INFORMATION
Insperity, Inc.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)March 31, 2025December 31, 2024
(in millions)
Assets
Cash and cash equivalents$551 $1,039 
Restricted cash74 69 
Marketable securities17 16 
Accounts receivable, net834 829 
Prepaid insurance and related assets56 25 
Income taxes receivable— 
Other current assets114 107 
Total current assets1,654 2,085 
Property and equipment, net186 192 
Right-of-use leased assets67 65 
Deposits and prepaid health insurance188 195 
Goodwill and other intangible assets, net13 13 
Deferred income taxes, net10 34 
Other assets25 13 
Total assets$2,143 $2,597 
Liabilities and stockholders' equity
Accounts payable$$10 
Payroll taxes and other payroll deductions payable457 901 
Accrued worksite employee payroll cost718 730 
Accrued health insurance costs68 19 
Accrued workers’ compensation costs76 71 
Accrued corporate payroll and commissions49 82 
Other accrued liabilities90 117 
Total current liabilities1,466 1,930 
Accrued workers’ compensation costs, net of current122 135 
Long-term debt369 369 
Operating lease liabilities, net of current67 66 
Total noncurrent liabilities558 570 
Stockholders’ equity:
Common stock
Additional paid-in capital209 222 
Treasury stock, at cost(855)(864)
Retained earnings764 738 
Total stockholders' equity119 97 
Total liabilities and stockholders’ equity$2,143 $2,597 



SUMMARY FINANCIAL INFORMATION
Insperity, Inc.
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)Three Months Ended March 31,
(in millions, except per share amounts)20252024Change
Operating results:
Revenues(1)
$1,863 $1,802 3 %
Payroll taxes, benefits and workers’ compensation costs1,553 1,457 %
Gross profit310 345 (10)%
Salaries, wages and payroll taxes142 140 %
Stock-based compensation11 10 10 %
Commissions11 12 (8)%
Advertising— 
General and administrative expenses60 57 %
Depreciation and amortization11 11 — 
Total operating expenses242 2372 %
Operating income68 108 (37)%
Other income (expense):
Interest income10 10 — 
Interest expense(6)(7)(14)%
Income before income tax expense72 111 (35)%
Income tax expense21 32 (34)%
Net income$51 $79 (35)%
Net income per share of common stock
Basic$1.37 $2.11 (35)%
Diluted$1.35 $2.08 (35)%
____________________________________
(1)Revenues are comprised of gross billings less WSEE payroll costs as follows:
Three Months Ended March 31,
(in millions)
20252024
Gross billings
$12,144 $11,483 
Less: WSEE payroll cost
10,281 9,681 
Revenues
$1,863 $1,802 



SUMMARY FINANCIAL INFORMATION
Insperity, Inc.
KEY FINANCIAL AND STATISTICAL DATA
Three Months Ended March 31,
20252024Change
Average WSEEs paid306,023 303,904 %
Statistical data (per WSEE per month):
Revenues(1)
$2,029 $1,977 %
Gross profit338 378 (11)%
Operating expenses264 260 %
Operating income74 118 (37)%
Net income56 87 (36)%
____________________________________
(1)Revenues per WSEE per month are comprised of gross billings per WSEE per month less WSEE payroll costs per WSEE per month follows:
Three Months Ended March 31,
(per WSEE per month)20252024
Gross billings$13,228 $12,595 
Less: WSEE payroll cost
11,199 10,618 
Revenues$2,029 $1,977 


NON-GAAP FINANCIAL MEASURES
Insperity, Inc.
Non-GAAP FINANCIAL MEASURES
(Unaudited)

Non-GAAP financial measures are not prepared in accordance with GAAP and may be different from non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. Investors are encouraged to review the reconciliation of the non-GAAP financial measures used to their most directly comparable GAAP financial measures as provided in the tables below.
Non-GAAP MeasureDefinitionBenefit of Non-GAAP Measure
Non-bonus payroll costNon-bonus payroll cost is a non-GAAP financial measure that excludes the impact of bonus payrolls paid to our WSEEs.Our management refers to non-bonus payroll cost in analyzing, reporting and forecasting our workers’ compensation costs.

Bonus payroll cost varies from period to period, but has no direct impact to our ultimate workers’ compensation costs under the current program.

We include these non-GAAP financial measures because we believe they are useful to investors in allowing for greater transparency related to the costs incurred under our current workers’ compensation program.
Adjusted cash, cash equivalents and marketable securitiesExcludes funds associated with:
•  federal and state income tax withholdings,
•  employment taxes,
•  other payroll deductions, and
•  client prepayments.
We believe that the exclusion of the identified items helps us reflect the fundamentals of our underlying business model and analyze results against our expectations, against prior periods, and to plan for future periods by focusing on our underlying operations. We believe that the adjusted results provide relevant and useful information for investors because they allow investors to view performance in a manner similar to the method used by management and improves their ability to understand and assess our operating performance. Adjusted EBITDA is used by our lenders to assess our leverage and ability to make interest payments.
EBITDARepresents net income computed in accordance with GAAP, plus:
•  interest expense,
•  income tax expense,
•  depreciation and amortization expense, and
•  amortization of SaaS implementation costs.
Adjusted EBITDARepresents EBITDA plus:
•  non-cash stock-based compensation.
Adjusted net incomeRepresents net income computed in accordance with GAAP, excluding:
•  non-cash stock-based compensation.
Adjusted EPSRepresents diluted net income per share computed in accordance with GAAP, excluding:
•  non-cash stock-based compensation.


NON-GAAP FINANCIAL MEASURES
Following is a reconciliation of payroll cost (GAAP) to non-bonus payroll costs (non-GAAP):
Three Months Ended March 31,
(in millions, except per WSEE per month)20252024
Per WSEEPer WSEE
Payroll cost
$10,281 $11,199 $9,681 $10,618 
Less: Bonus payroll cost
2,243 2,444 1,862 2,042 
Non-bonus payroll cost
$8,038 $8,755 $7,819 $8,576 
Payroll cost % change period over period
6 %5 % 1 %
Non-bonus payroll cost % change period over period
3 %2 %2 %3 %
Following is a reconciliation of cash, cash equivalents and marketable securities (GAAP) to adjusted cash, cash equivalents and marketable securities (non-GAAP):
(in millions)March 31,
2025
December 31,
2024
Cash, cash equivalents and marketable securities
$568 $1,055 
Less:
Amounts payable for withheld federal and state income taxes, employment taxes and other payroll deductions
404 830 
Client prepayments40 91 
Adjusted cash, cash equivalents and marketable securities
$124 $134 
Following is a reconciliation of net income (GAAP) to EBITDA (non-GAAP) and adjusted EBITDA (non-GAAP):
(in millions, except per WSEE per month)Three Months Ended March 31,
20252024
Per WSEEPer WSEE
Net income
$51 $56 $79 $87 
Income tax expense
21 22 32 35 
Interest expense
Amortization of SaaS implementation costs
Depreciation and amortization
11 12 11 12 
EBITDA
91 99 132 145 
Stock-based compensation
11 12 10 11 
Adjusted EBITDA
$102 $111 $142 $156 
Net income % change period over period(35)%(36)%(17)%(16)%
Adjusted EBITDA % change period over period(28)%(29)%(7)%(5)%


NON-GAAP FINANCIAL MEASURES
Following is a reconciliation of net income (GAAP) to adjusted net income (non-GAAP):
Three Months Ended March 31,
(in millions)20252024
Net income
$51 $79 
Non-GAAP adjustments:
Stock-based compensation11 10 
Tax effect(3)(3)
Total non-GAAP adjustments, net8 7 
Adjusted net income$59 $86 
Net income % change period over period(35)%(17)%
Adjusted net income % change period over period(31)%(17)%
Following is a reconciliation of diluted EPS (GAAP) to adjusted EPS (non-GAAP):
Three Months Ended March 31,
20252024
Diluted EPS
$1.35 $2.08 
Non-GAAP adjustments:
Stock-based compensation0.30 0.28 
Tax effect(0.08)(0.09)
Total non-GAAP adjustments, net0.22 0.19 
Adjusted EPS$1.57 $2.27 
Diluted EPS % change period over period(35)%(15)%
Adjusted EPS % change period over period(31)%(15)%



NON-GAAP FINANCIAL MEASURES


The following is a reconciliation of GAAP to non-GAAP financial measures for second quarter and full year 2025 guidance:
Q2 2025Full Year 2025
(in millions, except per share amounts)GuidanceGuidance
Net income (loss)
$(3) - $11 $42 - $81 
Income tax expense (benefit)
(1) - 5 17 - 33 
Interest expense
25 
SaaS implementation amortization
Depreciation and amortization
1142
EBITDA
14 - 34130 - 185
Stock-based compensation
1960
Adjusted EBITDA
$33 - $53$190 - $245
Diluted EPS
$(0.07) - $0.31 $1.10 - $2.15 
Non-GAAP adjustments:
Stock-based compensation
0.50 1.59 
Tax effect(0.14)(0.46)
Total non-GAAP adjustments, net0.36 1.13 
Adjusted EPS
$0.29 - $0.67 $2.23 - $3.28